YorkBridge Wealth Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

YorkBridge Wealth Partners’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-352	Closed	-$36K	–	911
2017 Q4	$36K	Sell	352 -338	-49%	-$18.5K	0.02%	409
2017 Q3	$39K	Sell	690 -26	-4%	-$1.52K	0.02%	409
2017 Q2	$44K	Sell	716 -616	-46%	-$35.1K	0.02%	387
2017 Q1	$77K	Buy	+1,332	New	+$65.6K	0.04%	317

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

YorkBridge Wealth Partners's BIVV Position: Q1 2018 in Review

YorkBridge Wealth Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 352 shares — an estimated $36K sold.

YorkBridge Wealth Partners first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $77K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

YorkBridge Wealth Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
YorkBridge Wealth Partners sold 352 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $36K.
YorkBridge Wealth Partners first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
YorkBridge Wealth Partners's Bioverativ Inc. Common Stock position peaked at $77K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q1 2018, filed 15 May 2018.